Cancer Cell：陈云/滕皋军合作发现，肿瘤内细菌增强肝癌免疫治疗效果
Ranking
Overall
82
Content
95
Popularity
N/A
No observed public metrics; popularity remains neutral/archived.
Merged summary
TL;DR - A Cancer Cell study identifies a stem-like lymphoid niche (SLN) that predicts stronger PD-1/PD-L1 immunotherapy responses in hepatocellular carcinoma. Intratumoral Bacillus cereus promotes these niches through secreted PI-PLC, suggesting a microbiome-mediated strategy for improving treatment.
- Spatial multi-omics showed that SLNs contain CD70+ ILC2 cells and TCF1+ precursor-exhausted T cells, distinguishing them from conventional tertiary lymphoid structures.
- B. cereus-derived PI-PLC triggers endothelial IL-33 release, reshaping ILC2 metabolism and epigenetically activating lymphoid-organizing genes.
- Greater SLN abundance was associated with better immune-checkpoint-blockade response.
- Combining PI-PLC with PD-L1 blockade produced synergistic antitumor immunity in the study’s liver-cancer models.
Sources (1)
Cancer Cell：陈云/滕皋军合作发现，肿瘤内细菌增强肝癌免疫治疗效果
Public signals
N/A
TL;DR - A Cancer Cell study identifies a stem-like lymphoid niche (SLN) that predicts stronger PD-1/PD-L1 immunotherapy responses in hepatocellular carcinoma. Intratumoral Bacillus cereus promotes these niches through secreted PI-PLC, suggesting a microbiome-mediated strategy for improving treatment.
- Spatial multi-omics showed that SLNs contain CD70+ ILC2 cells and TCF1+ precursor-exhausted T cells, distinguishing them from conventional tertiary lymphoid structures.
- B. cereus-derived PI-PLC triggers endothelial IL-33 release, reshaping ILC2 metabolism and epigenetically activating lymphoid-organizing genes.
- Greater SLN abundance was associated with better immune-checkpoint-blockade response.
- Combining PI-PLC with PD-L1 blockade produced synergistic antitumor immunity in the study’s liver-cancer models.